Example: Heart Attack

Search clinical trials for: Muscle Relaxants, Central

Total 322 results

NCT04671082

Recruiting

Efficacy and Safety of Tolperisone in Subjects With Pain Due to Acute Back Muscle Spasm

Conditions: Back Muscle Spasm; Back Pain; Back Strain; Back Spasm Upper; Muscle Spasm; Acute Pain
NCT03802565

Completed

Tolperisone in Acute Muscle Spasm of the Back

Conditions: Back Pain; Acute Pain; Back Spasm Upper Back; Back Strain; Muscle Cramp; Muscle Spasm; Low Back Pain
NCT04134845

Recruiting

A Clinical Trial Utilizing Dantrolene in Patients With Ventricular Arrhythmias.

Conditions: Ventricular Tachycardia
NCT03762109

Recruiting

The Use of Dantrolene to Improve Analgesia in Posterior Lumbar Surgery

Conditions: Lumbar Spine Injury
NCT03600376

Completed

Study to Assess the Efficacy and Safety of Ryanodex as Adjuvant Treatment in Subjects With EHS

Conditions: Exertional Heat Stroke
NCT04765202

Not yet recruiting

StrataGraft Overlay of Meshed Autograft in Full-thickness Thermal Burns

Conditions: Full Thickness Burn
NCT04465266

Active, not recruiting

A Phase 1 PK Study of Tolperisone in Healthy Subjects

Conditions: Healthy
NCT04458454

Completed

"Study of the Effects of Serum and Follicular Fluid Relaxin Levels on Ovarian Function in IVF Cycles"

Conditions: Infertility; Reproductive Techniques, Assisted; Oocyte Maturation
NCT03189433

Terminated

Efficacy and Safety Study of Ryanodex as Adjuvant Treatment in Subjects With Psychostimulant Drug-Induced Toxicity (PDIT)

Conditions: Drug Toxicity Psychotropic Agents Psychostimulants
NCT02829268

Active, not recruiting

A Clinical Trial of Dantrolene Sodium in Pediatric and Adult Patients With Wolfram Syndrome

Conditions: Wolfram Syndrome; Diabetes Mellitus; Optic Nerve Atrophy; Ataxia
NCT02513095

Completed

Efficacy and Safety of Ryanodex® (EGL-4104) as Adjuvant Treatment in Subjects With Exertional Heat Stroke (EHS)

Conditions: Heat Stroke
NCT02405104

Completed

Chlorzoxazone in Hip and Knee Arthroplasty

Conditions: Osteoarthritis of Hip; Osteoarthritis, Knee
NCT01342341

Completed

Placebo-Controlled Cross Over Trial of Chlorzoxazone Intake

Conditions: Alcohol Abuse
NCT00964548

Completed

Safety Study of Dantrolene to Treat Cerebral Vasospasm After Subarachnoid Hemorrhage

Conditions: Cerebral Vasospasm After Subarachnoid Hemorrhage
NCT00796900

Terminated

Dantrolene for Treatment of Hyperthermia in Subarachnoidal Hemorrhage (SAH)

Conditions: Hyperthermia
NCT00704665

Completed

Recombinant Human Relaxin in the Treatment of Diffuse Scleroderma

Conditions: Systemic Sclerosis
NCT00671879

Completed

Study to Evaluate Two Formulations of Carisoprodol in Subjects With Musculoskeletal Spasm of the Lower Back

Conditions: Lower Back Pain
NCT00671502

Completed

A Study to Evaluate Two Formulations of Carisoprodol in Subjects With Musculoskeletal Spasm of the Lower Back

Conditions: Lower Back Pain
NCT00532532

Terminated

Safety and Preliminary Effectiveness of AV650 in Patients With Spasticity Associated With Multiple Sclerosis

Conditions: Muscle Spasticity
NCT00531466

Terminated

Safety and Preliminary Effectiveness of AV650 in Patients With Spasticity Due to Spinal Cord Injury

Conditions: Muscle Spasticity
NCT00520806

Completed

Efficacy and Safety of Relaxin for the Treatment of Acute Heart Failure

Conditions: Heart Failure, Congestive
NCT00406575

Terminated

Recombinant Human Relaxin for the Treatment of Decompensated CHF

Conditions: Congestive Heart Failure (CHF)
NCT00333307

Suspended

Evaluation of the Safety of Relaxin in Preeclampsia

Conditions: Pre-Eclampsia
NCT00259116

Completed

A Pilot Study of Recombinant Human Relaxin (rhRlx) in Compensated Congestive Heart Failure

Conditions: Heart Failure, Congestive
NCT00004380

Completed

Phase II Study of Recombinant Relaxin for Progressive Systemic Sclerosis

Conditions: Systemic Sclerosis